SHUKRA PHARMACEUTICALS
|
SHUKRA PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹11 Cr | ₹3.91 Cr | ₹1.57 Cr | ₹1.57 Cr | ₹1.57 Cr |
Equity - Authorised | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
Equity - Issued | ₹11 Cr | ₹11 Cr | ₹1.57 Cr | ₹1.57 Cr | ₹1.57 Cr |
Equity Paid Up | ₹11 Cr | ₹3.91 Cr | ₹1.57 Cr | ₹1.57 Cr | ₹1.57 Cr |
Equity Shares Forfeited | ₹0.00 Cr | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹47 Cr | ₹21 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr |
Securities Premium | ₹9.12 Cr | ₹2.28 Cr | - | - | - |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹38 Cr | ₹19 Cr | ₹15 Cr | ₹14 Cr | ₹9.69 Cr |
General Reserves | - | - | - | - | ₹0.13 Cr |
Other Reserves | ₹0.01 Cr | ₹-0.01 Cr | - | - | ₹4.03 Cr |
Reserve excluding Revaluation Reserve | ₹47 Cr | ₹21 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹58 Cr | ₹25 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹1.25 Cr | ₹0.90 Cr | ₹0.85 Cr | ₹0.66 Cr | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹1.38 Cr | ₹1.10 Cr | ₹0.99 Cr | ₹0.66 Cr | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-0.13 Cr | ₹-0.21 Cr | ₹-0.14 Cr | - | - |
Unsecured Loans | ₹1.41 Cr | ₹2.87 Cr | ₹2.28 Cr | ₹9.11 Cr | ₹8.05 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹1.41 Cr | ₹2.87 Cr | ₹2.28 Cr | ₹9.11 Cr | ₹8.05 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹3.27 Cr | ₹3.29 Cr | ₹3.26 Cr | ₹3.20 Cr | ₹3.10 Cr |
Deferred Tax Assets | ₹0.01 Cr | - | - | - | - |
Deferred Tax Liability | ₹3.29 Cr | ₹3.29 Cr | ₹3.26 Cr | ₹3.20 Cr | ₹3.10 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.12 Cr | ₹0.11 Cr | - | - | - |
Total Non-Current Liabilities | ₹6.04 Cr | ₹7.16 Cr | ₹6.39 Cr | ₹13 Cr | ₹11 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹7.22 Cr | ₹34 Cr | ₹8.59 Cr | ₹5.33 Cr | ₹6.46 Cr |
Sundry Creditors | ₹7.22 Cr | ₹34 Cr | ₹8.59 Cr | ₹5.33 Cr | ₹6.23 Cr |
Acceptances | - | - | - | - | ₹0.23 Cr |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹6.03 Cr | ₹8.78 Cr | ₹3.47 Cr | ₹0.94 Cr | - |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹3.53 Cr | ₹6.61 Cr | ₹2.47 Cr | ₹0.85 Cr | - |
Interest Accrued But Not Due | - | - | ₹0.01 Cr | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹2.50 Cr | ₹2.17 Cr | ₹1.00 Cr | ₹0.09 Cr | - |
Short Term Borrowings | - | - | - | - | - |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | - | - |
Short Term Provisions | ₹0.90 Cr | ₹0.10 Cr | ₹0.32 Cr | ₹0.77 Cr | ₹0.53 Cr |
Proposed Equity Dividend | ₹0.03 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.05 Cr | ₹0.02 Cr |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | ₹0.03 Cr | ₹0.13 Cr |
Provision for post retirement benefits | ₹0.04 Cr | ₹0.03 Cr | ₹0.28 Cr | ₹0.00 Cr | ₹0.38 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.84 Cr | ₹0.03 Cr | - | ₹0.69 Cr | - |
Total Current Liabilities | ₹14 Cr | ₹43 Cr | ₹12 Cr | ₹7.04 Cr | ₹6.99 Cr |
Total Liabilities | ₹78 Cr | ₹75 Cr | ₹35 Cr | ₹36 Cr | ₹34 Cr |
ASSETS | |||||
Gross Block | ₹41 Cr | ₹40 Cr | ₹35 Cr | ₹34 Cr | ₹32 Cr |
Less: Accumulated Depreciation | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹16 Cr | ₹14 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹20 Cr | ₹20 Cr | ₹18 Cr | ₹18 Cr | ₹17 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹1.66 Cr | ₹1.66 Cr | ₹1.66 Cr | ₹1.66 Cr | ₹1.66 Cr |
Non Current Investments | - | - | - | ₹0.20 Cr | ₹0.05 Cr |
Long Term Investment | - | - | - | ₹0.20 Cr | ₹0.05 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | ₹0.20 Cr | ₹0.05 Cr |
Long Term Loans & Advances | - | - | - | - | - |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹22 Cr | ₹22 Cr | ₹19 Cr | ₹20 Cr | ₹19 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹2.31 Cr | ₹3.16 Cr | ₹3.95 Cr | ₹1.68 Cr | ₹1.39 Cr |
Raw Materials | ₹1.23 Cr | ₹1.37 Cr | ₹2.50 Cr | ₹0.96 Cr | ₹0.86 Cr |
Work-in Progress | ₹1.09 Cr | ₹1.79 Cr | ₹1.45 Cr | ₹0.68 Cr | ₹0.49 Cr |
Finished Goods | - | - | - | - | - |
Packing Materials | - | - | - | ₹0.04 Cr | ₹0.04 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹25 Cr | ₹30 Cr | ₹7.40 Cr | ₹9.75 Cr | ₹7.95 Cr |
Debtors more than Six months | ₹6.30 Cr | ₹1.21 Cr | ₹2.06 Cr | ₹0.30 Cr | - |
Debtors Others | ₹18 Cr | ₹29 Cr | ₹5.34 Cr | ₹9.45 Cr | ₹7.95 Cr |
Cash and Bank | ₹9.98 Cr | ₹3.97 Cr | ₹0.29 Cr | ₹0.50 Cr | ₹0.13 Cr |
Cash in hand | ₹0.17 Cr | ₹0.04 Cr | ₹0.05 Cr | ₹0.28 Cr | ₹0.08 Cr |
Balances at Bank | ₹9.82 Cr | ₹3.94 Cr | ₹0.24 Cr | ₹0.23 Cr | ₹0.05 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹6.19 Cr | ₹7.97 Cr | ₹0.17 Cr | ₹0.14 Cr | ₹1.22 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.02 Cr | ₹0.02 Cr | ₹0.06 Cr | ₹0.03 Cr | - |
Other current_assets | ₹6.17 Cr | ₹7.95 Cr | ₹0.11 Cr | ₹0.11 Cr | ₹1.22 Cr |
Short Term Loans and Advances | ₹13 Cr | ₹7.79 Cr | ₹4.06 Cr | ₹3.98 Cr | ₹3.77 Cr |
Advances recoverable in cash or in kind | ₹10 Cr | ₹4.85 Cr | ₹0.94 Cr | ₹0.52 Cr | ₹0.08 Cr |
Advance income tax and TDS | ₹0.34 Cr | ₹0.26 Cr | ₹0.57 Cr | - | ₹0.22 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹2.45 Cr | ₹2.67 Cr | ₹2.55 Cr | ₹3.46 Cr | ₹3.47 Cr |
Total Current Assets | ₹56 Cr | ₹53 Cr | ₹16 Cr | ₹16 Cr | ₹14 Cr |
Net Current Assets (Including Current Investments) | ₹42 Cr | ₹11 Cr | ₹3.50 Cr | ₹9.03 Cr | ₹7.47 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹78 Cr | ₹75 Cr | ₹35 Cr | ₹36 Cr | ₹34 Cr |
Contingent Liabilities | - | - | ₹1.40 Cr | - | - |
Total Debt | ₹3.15 Cr | ₹5.08 Cr | ₹3.38 Cr | ₹9.77 Cr | ₹8.05 Cr |
Book Value | - | 64.63 | 104.43 | 99.63 | 98.43 |
Adjusted Book Value | 13.17 | 16.16 | 5.43 | 5.18 | 5.12 |
Compare Balance Sheet of peers of SHUKRA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHUKRA PHARMACEUTICALS | ₹491.4 Cr | 21.5% | 86% | 227.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹436,103.0 Cr | 1% | 0.7% | 47.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,540.0 Cr | -1.1% | -5.8% | 61.7% | Stock Analytics | |
CIPLA | ₹119,196.0 Cr | 0.3% | -1.8% | 19.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,752.0 Cr | 6% | 11.8% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,041.2 Cr | -1.5% | -0.1% | 47% | Stock Analytics |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHUKRA PHARMACEUTICALS | 21.5% |
86% |
227.7% |
SENSEX | -2.7% |
-0.8% |
9.9% |
You may also like the below Video Courses